Cancer drug trial halted early: PRT7732 studied for rare gene mutation
Disease control
Terminated
This early-stage study tested an experimental oral drug called PRT7732 in people with advanced solid tumors (like lung or stomach cancer) that have a specific genetic change called SMARCA4. The main goals were to check safety, find the right dose, and see if the drug shrinks tumo…
Phase: PHASE1 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:57 UTC